| GTO ID | GTC2093 |
| Trial ID | NCT03916679 |
| Disease | Ovarian Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Other ID(s) | MESO-OS |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||